Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Atorvastatin 40 mg vs Lipitor 40 mg in healthy Thai volunteers (fasting)
TCTR20190315002Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of atorvastatin in hypercholesterolemia, combined dyslipidaemia and hyperlipidemia (2 arms), sponsored by Bio-innova. Primary endpoint: Primary pharmacokinetic bioequivalence parameters. Planned start Apr 2020; status: not yet recruiting.
02
Drugs
atorvastatin
03
Conditions
hypercholesterolemiacombined dyslipidaemiahyperlipidemia
Beyond the preview
Go deeper on TCTR20190315002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20190315002.